SEC Form 4 · accession 0000719135-18-000065
Apyx Medical Corp · APYX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Craig A. Swandal
Director
Period of report
Aug 30, 2018
Accepted (ET)
Sep 10, 2018 · 11:31 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000719135
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Option to Buy)F1 | $5.30 | Aug 30, 2018 | A | 24,000 | A | Aug 30, 2019 | Aug 29, 2028 | Common Stock | 24,000 | 24,000 | D |
Explanation of responses
- F1Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant.